Searched for
NORTH AMERICA GENERICS
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...29 May, 2026, 05.30 AM IST- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...29 May, 2026, 12.57 AM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIf the US-Iran ceasefire holds, the markets may see some recovery. The movement of crude oil prices and its impact on the markets supports ...27 May, 2026, 11.39 PM IST
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...23 May, 2026, 10.24 PM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the latest news flow from the Gulf region, the probability is high that we might once again see the bulls attempting a comeback. As u...20 May, 2026, 10.41 PM IST
- Cipla Q4 Results: Profit falls 55% YoY to Rs 555 crore; co declares Rs 13/sh dividendCipla Ltd announced a significant 55% year-on-year drop in its consolidated net profit for the fourth quarter, reaching Rs 555 crore. This ...13 May, 2026, 01.18 PM IST
- Dr Reddy's shares in focus after Q4 net profit tumbles 86% YoY; Morgan Stanley, Goldman Sachs weigh inDr. Reddy's Laboratories shares: The pharma major posted a sharp 86% YoY drop in Q4FY26 consolidated net profit to Rs 221 crore, compared w...13 May, 2026, 09.13 AM IST
- Dr Reddy's Laboratories Q4 Results: Cons PAT falls 86% YoY to Rs 221 crore, revenue dips 12%; Rs 8 per share dividend announcedDr Reddy's Laboratories Q4 Results: Dr. Reddy's Laboratories reported a consolidated net profit at Rs 221 crore in the March-ended quarter ...12 May, 2026, 05.08 PM IST
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...05 May, 2026, 05.35 PM IST
- Outlook login not working? What caused Microsoft Outlook outage today — and was it Hacked?Is Outlook Down Right Now? Outlook login not working? What caused the Microsoft Outlook outage today — and was it hacked? Microsoft stayed ...27 Apr, 2026, 05.28 PM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...22 Apr, 2026, 10.08 PM IST
- Pharma exports fall to five-year low in March amid West Asia crisisIndia's pharma exports saw a sharp 23.17% fall in March. The West Asia war disrupted shipping routes and air transit hubs. This led to incr...17 Apr, 2026, 12.58 AM IST
- Dr Reddy's launches authorised generic of Vasostrict injection“We are pleased to provide this important authorized generic product to patients, especially in these difficult times of COVID-19,” says Ma...09 Feb, 2022, 07.21 PM IST
- Dr Reddy's launches generic epilepsy drug in US market"We are pleased that this product has been designated as a Competitive Generic Therapy (CGT) by the FDA," Dr Reddy's Laboratories North Ame...02 Feb, 2021, 03.02 PM IST
- Dr Reddy's launches generic arthritis drug in US market"The launch of product is an important addition to our pain/analgesics portfolio of over-the-counter (OTC) products, and represents our con...09 Sep, 2020, 12.30 PM IST
- Dr Reddy's picks Alok Sonig to lead North America generics businessIn a top level reshuffle, drug major Dr Reddy's Laboratories appointed Alok Sonig as Executive Vice President & Head for its generics busin...27 Aug, 2015, 09.05 PM IST
- Dr Reddy's expects North American biz to drive growth this FYDr Reddy's Laboratories expects generics business in North America to be its main growth driver this fiscal.07 Aug, 2011, 11.02 AM IST
Load More
